Geneva, Switzerland · Est. 2026
Where science
meets strategy.
A multi-arm global health institute operating at the intersection of evidence, strategy, learning, and artificial intelligence.
Research. Learning. Intelligence. Advisory.
One institute. Four capabilities.
Helix Global Institute brings together a research core, a professional learning platform, an AI capability, and a strategic advisory practice — all unified under one identity, serving governments and institutions where the evidence is needed most.
Branch 01
Evidentia
A professional learning platform for global health practitioners, researchers, and institutions — in English and French. Includes the AI Academy (Académie IA), live workshops, certification pathways, and enterprise packages.
Explore Evidentia Branch 02NCD Research & Innovation Institute
Noncommunicable disease research, cardiovascular disease epidemiology, and implementation science. Backed by 38+ peer-reviewed publications in JACC, JAMA Cardiology, BMJ Global Health, and The Lancet.
View our research Branch 03Consulting & Strategy
Health systems advisory, noncommunicable disease policy and programme design, AI in health strategy, and institutional partnerships. Available for governments, international institutions, and the private sector.
View our services Within EvidentiaAI Academy — Académie IA
Dedicated training in artificial intelligence for public health professionals and institutions. Courses, workshops, and certifications on AI applications in health systems, disease surveillance, and policy.
Explore AI AcademyImpact in numbers
38+
Peer-reviewed publications in leading international journals
37
Countries covered in landmark cardiovascular disease research
194
WHO Member States served through technical leadership
156M
Adults surveyed across multi-country STEPS studies
Founded by
Dr Kouamivi Agboyibor
Founder & Scientific Director of Helix Global Institute and Technical Lead, Cardiovascular Disease Management Programme, at WHO Headquarters in Geneva.
With more than 12 years of technical leadership across 194 WHO Member States, Dr Agboyibor brings a rare combination of epidemiological rigour, policy expertise, and implementation experience to every engagement of the institute.
Meet the founderSelected research
From the NCD Research & Innovation Institute
Hypertension prevalence and time trends across 37 WHO African Region countries
Determinants and time trends of cardiovascular health across the WHO African Region
Work with Helix Global Institute.
Advisory engagements, research partnerships, Evidentia corporate training, and speaking invitations are now open. We serve governments, international organisations, academic institutions, foundations, and the private sector.